Last month, we released a brief clip from a call our Health Policy analyst Emily Evans held with institutional subscribers. In it, Evans highlighted three big pharma stocks she believed stand to win big under the Trump plan.
- Roche Holdings (RHHBY)
- Johnson & Johnson (JNJ)
- Eli Lilly (LLY)
Here's how each of these stocks have fared since her call.
Here's the video clip.